Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | SVP, Chief Financial Officer | $534K | Jul 28, 2022 | ||
AGRX, AGXRW | AGILE THERAPEUTICS INC | Chief Financial Officer | $0 | Aug 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|